Status:
COMPLETED
A Prospective and Observational Cohort Study to Evaluate the Treatment Model and Medical Economics of Advanced Gastric Cancer Chemotherapy in Clinical Practice in China
Lead Sponsor:
Peking University
Conditions:
Advanced Gastric Cancer
Eligibility:
All Genders
18-85 years
Brief Summary
This is a multi-center, prospective and observational clinical study. Eligible patients will accept generalized chemotherapy according to the investigator's assessment. Information related to the trea...
Eligibility Criteria
Inclusion
- The patient has histologically confirmed locally-advanced or recurrent and/or metastatic gastric or esophagogastric junction adenocarcinoma, has missed the opportunity of surgical excision, making curative therapy impossible.
- The informed consent form is signed.
- A specimen of tumor tissue (puncture biopsy or surgical specimen) is available.
- ECOG performance status is 0, 1 or 2.
- The patient's general conditions and functions of important organs allow generalized chemotherapy according to the investigator's judgment
- The patient is aged≥18
Exclusion
- The patient is known to be allergic to any study drug.
- The patient is recruited in other clinical study or is planned to participate into other clinical study.
- The patient has previously accepted chemotherapy against advanced or metastatic diseases (the patient may be recruited if the previous adjuvant therapy/neoadjuvant therapy was completed more than 6 months before inclusion).
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2016
Estimated Enrollment :
498 Patients enrolled
Trial Details
Trial ID
NCT01472250
Start Date
November 1 2011
End Date
July 1 2016
Last Update
May 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lin Shen
Beijing, Beijing Municipality, China, 100142